Results 201 to 210 of about 50,819 (268)

Response Shift and Item Interpretation: Two Caveats for Using Minimal Symptom Expression as a Treatment Goal in Generalised Myasthenia Gravis

European Journal of Neurology, Volume 33, Issue 9, September 2026.
Hai‐Feng Li, Qi Li, Yu‐Zhou Guan, Huan Yang   +3 more
wiley   +1 more source

Regarding: Myasthenia gravis following the initiation of statin therapy. [PDF]

J Intern Med
Zeng S, Shi Z.
europepmc   +1 more source

Myasthenia Gravis [PDF]

Postgraduate Medical Journal, 1939
openaire   +2 more sources

The treatment with or without prednisolone in adults aged ≥ 70 years with myasthenia gravis: a retrospective cohort study. [PDF]

Front Neurol
Iwasa K, Furukawa Y, Yoshikawa H, Noguchi-Shinohara M, Ono K.   +4 more
europepmc   +1 more source

Myasthenia Gravis [PDF]

Postgraduate Medical Journal, 1965
openaire   +2 more sources

Clinical Course After a Single Cycle of Rozanolixizumab in Generalized Late-Onset Myasthenia Gravis. [PDF]

J Clin Neurol
Aritake S, Nagai A.
europepmc   +1 more source

Case Report: Use of telitacicept for ocular myasthenia gravis. [PDF]

Front Immunol
Yang A, Zhao J, Li F, Pang R, Zang W.
europepmc   +1 more source

Thymoma-Associated Systemic Lupus Erythematosus and Myasthenia Gravis. [PDF]

Case Rep Rheumatol
González-Ramos K, Rivera-Burgos I, Cedeño C, Lafontaine J, Marcos-Martínez MJ, Vilá LM.   +5 more
europepmc   +1 more source

Factors Influencing the Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis: A Retrospective Cohort Study. [PDF]

J Ophthalmol
Chuenkongkaew W, Chirapapaisan N, Chatchutimakorn P, Rattanathamsakul N, Joradoln M, Kongthanasomboon P, Eiamsamarng A.   +6 more
europepmc   +1 more source